Parties Debate Adequacy of GLP-1 Label Warnings On April 9, lawyers representing the drug makers and plaintiffs involved in the litigation each submitted position papers to Judge Pratter, explaining their differing opinions on the litigation, which will largely focus on whether the label warnings for Ozempic, Mounjaro, Wegovy and Zepbound adequately disclosed the risks of gastroparesis and other intestinal injuries
Tirzepatide may be helpful for some patients who are dealing with weight gain, insulin resistance, blood sugar concerns, or weight-related cardiovascular risk factors
Frequently asked questions Medically reviewed by:Dr
Diet strategies during and after a GLP-1 reset Your nutrition approach during a reset period requires deliberate planning
Once the trigger is corrected for example, rapid weight loss slows down, calorie intake improves, or deficiencies are treated the hair cycle often begins to normalise
It was driven by genuine changes in hunger signaling, food preference, and the reward value of eating